Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx. 20% of patients with hypertension develop diabetes. This combination of cardiovascular risk factors will account for a large proportion of cardiovascular morbidity and mortality. Lowering elevated blood pressure in diabetic hypertensive individuals decreases cardiovascular events. In patients with hypertension and diabetes, the pathophysiology of cardiovascular disease is multifactorial, but recent evidence points toward the presence of an important component dependent on a low-grade inflammatory process. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of pro-inflammatory transcription factors such as NF-κB (nuclear factor κB). These, in turn, regulate the generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury. Inflammatory markers (e.g. C-reactive protein, chemokines and adhesion molecules) are increased in patients with hypertension and metabolic disorders, and predict the development of cardiovascular disease. Lifestyle modification and pharmacological approaches (such as drugs that target the renin–angiotensin system) may reduce blood pressure and inflammation in patients with hypertension and metabolic disorders, which will reduce cardiovascular risk, development of diabetes and cardiovascular morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Savoia and Schiffrin, 2007
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Research works printed but not linked: 1
- Schöbeck, 2004, Inflammation, immunity, and HMG-CoA reductase inhibitors statins as anti-inflammatory agents?, Circulation, 109, II18
Cited by
Items 301–332 of 332
ST UDY OF GLYCOSYLATED HEMOGLOBIN LEVELS IN HYPERTENSIVE AND NORMOTENSIVE NON DIABETIC POPULATION
Arya, A., Saxena, T., Mundada, K., & Malvi, M. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/1414
Lunkes, G. I. (2008) · Americanae (AECID Library)
Brandão, R. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-27082018-105235
Dietary Factors, Type 2 Diabetes and Diabetic Retinopathy
Dow, C. (2018) · theses.fr (ABES) · doi:10.70675/9d5e839eze639z4539z9047z9003673ad2ea
Incorporating patient blood pressure levels into daily insulin dosing regimens
Hafsa, J. (2018) · BRAC University Institutional Repository (BRAC University)
Ferreira, N. D. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-10102018-155917
Screening strategies for dysglycaemia in relation to cardiovascular risk
Shahim, B. (2019) · Figshare · Cited by 1
Nutrients Intake and Hypertension
Fantin, F. (2020) · MDPI eBooks · doi:10.3390/books978-3-03928-663-8
Lee, D., Choi, B., Yoon, D., Kim, H., Lee, M., Kim, G., & Lee, Y. (2020) · Molecules · doi:10.3390/molecules25143269
Immune Mechanisms in Vascular Remodeling in Hypertension
Schiffrin, E. L. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-47801-8_7
Self-citationNarab, M. M., Siassi, F., & Koohdani, F. (2020)
Saxena, Y., Gupta, R., Kotwal, A., & Ojha, A. (2021) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_399_2020
14aPS-87 イオンの拡散により相互作用する電位依存性イオンチャネルの協同性(ポスターセッション, 領域 11)
矢野, 晶., & 蛯名, 邦. (2004) · 日本物理学会講演概要集
Genetics of Cardiovascular Risk in Obesity
Blackett, P. R., & Sanghera, D. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_13 · Cited by 1
Faculty Opinions recommendation of Aldosterone activates endothelial exocytosis.
Lederer, E. D. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1158148.618257
Rosei, E. A., & Rizzoni, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-15603-3_10
Mechanisms of Action of Berry Bioactives on the Vascular System
Babu, P. V. A., & Klimis‐Zacas, D. J. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165450-00166
Amir, A. (2023) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20230245
Ye, X., Zhang, H., Li, Q., Li, C.-S., Zhao, C.-J., Xia, L., Ren, H., Wang, X.-X., Yang, C., Wang, Y.-J., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.91200 · Cited by 1
Ni, J., Jin, C. G., Xu, C., Ni, S., & Lv, L. (2025) · Health Science Reports · doi:10.1002/hsr2.71585
“Angiotensin II aggravates inflammation within vessels by enhancing OS, which modulates recruitment of inflammatory factors like IL ‐ 6 [52].”
Khuu, L. (2010) · UWSpace (University of Waterloo) · Cited by 1
Poitras, V. J. (2009) · University Microfilms International eBooks
Khalesi Taharoom, S. (2016) · Griffith Research Online · doi:10.25904/1912/3864
Endothelial Dysfunction Biomarkers in Chronic Hypertension and Their Clinical
Hassan, Z. L., Abdullah, S. R., Kareem, S. A. A., & Mohsein, O. A. (2025) · Academia Open · doi:10.21070/acopen.10.2025.12662
“Essential hypertension is marked by changes in the structure and function of resistance vessels, which cause peripheral arterial resistance to rise [7].”
Li, K., Li, D., Gong, D., Ren, D., li, M., Wu, Y., Dong, H., & Wang, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-8827280/v1
Neuro-angiopathie diabétique : rôle des molécules de guidance neuronale
Mantsounga, C. (2015) · theses.fr (ABES) · doi:10.70675/a5a187e3z2aecz4f51z9e2ezabb53e937dc4
Guillot, A. (2017) · theses.fr (ABES) · doi:10.70675/7d1e98dazb6daz4d7czb9ecz53160b588214 · Cited by 2
Étude des effets des maladies cardio-métaboliques sur l’anatomie de la microcirculation rétinienne
Gallo, A. (2020) · theses.fr (ABES) · doi:10.70675/26d7258ezcebaz4498z841bz72fd6ff6913b
Huang, T., Peng, J., Li, C., Ren, Y., Kuang, Y., Zhang, W., Yao, Y., Wang, Y., Du, Z., He, X., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26116 · Cited by 1
Fathi, M., Moghadam, H. M., Fathi, M., Hajiesmaeili, M., Nooraei, N., Alamdari, N. M., Jame, S. Z. B., Khataee, F. H., & Moghaddam, N. M. (2026) · Health Science Reports · doi:10.1002/hsr2.72848
Shared Biomarkers of Arterial Hypertension and Atherosclerosis Development: Current State Analysis
Blagov, A. V., Sazonova, M. A., Ryzhkova, A., Sazonova, M. D., Popov, M. A., Sinyov, V. V., Omelchenko, A. V., Mishina, A. V., Metelkin, A. A., Tarakanov, I. A., et al. (2026) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2026.26.04.090
Metadata
- Authors
- Savoia, C., & Schiffrin, E. L.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-03-01
- Volume
- 112
- Issue
- 7
- Pages
- 375-384
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1975582897
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 21 · 2013: 23 · 2012: 21
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- vascular inflammation, hypertension, type 2 diabetes, angiotensin II, oxidative stress, NF-κB, endothelial dysfunction, cardiovascular risk, C-reactive protein, chemokines, adhesion molecules, renin-angiotensin system, blood pressure reduction, lifestyle modification
- MeSH terms
- Aldosterone, Angiotensin II, Diabetes Mellitus, Type 2, Humans, Hypertension, Renin-Angiotensin System, Vasculitis, Cell Adhesion Molecules, Cytokines, NF-kappa B, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.